Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM

Holistic medicine is an interdisciplinary field of study that integrates all types of biological information (protein, small molecules, tissues, organs, external environmental signals, etc.) to lead to predictive and actionable models for health care and disease treatment. Despite the global and integrative character of this discipline, a comprehensive picture of holistic medicine for the treatment of complex diseases is still lacking. In this study, we develop a novel systems pharmacology approach to dissect holistic medicine in treating cardiocerebrovascular diseases (CCDs) by TCM (traditional Chinese medicine). Firstly, by applying the TCM active ingredients screened out by a systems-ADME process, we explored and experimentalized the signed drug-target interactions for revealing the pharmacological actions of drugs at a molecule level. Then, at a/an tissue/organ level, the drug therapeutic mechanisms were further investigated by a target-organ location method. Finally, a translational integrating pathway approach was applied to extract the diseases-therapeutic modules for understanding the complex disease and its therapy at systems level. For the first time, the feature of the drug-target-pathway-organ-cooperations for treatment of multiple organ diseases in holistic medicine was revealed, facilitating the development of novel treatment paradigm for complex diseases in the future.

[1]  Chao Huang,et al.  Systems pharmacology in drug discovery and therapeutic insight for herbal medicines , 2014, Briefings Bioinform..

[2]  Yonghua Wang,et al.  Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. , 2013, Journal of ethnopharmacology.

[3]  J. Trojanowski,et al.  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.

[4]  A. Walters,et al.  The relationship among restless legs syndrome (Willis–Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease , 2013, Journal of Neurology.

[5]  Jinan Wang,et al.  Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. , 2013, Journal of ethnopharmacology.

[6]  Xue Xu,et al.  Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. , 2013, Journal of ethnopharmacology.

[7]  Yonghua Wang,et al.  Systems pharmacology uncovers Janus functions of botanical drugs: activation of host defense system and inhibition of influenza virus replication , 2012, Integrative biology : quantitative biosciences from nano to macro.

[8]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[9]  L. Hood,et al.  A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.

[10]  Xue Xu,et al.  A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.

[11]  Hua Yu,et al.  A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.

[12]  Paul J Thornalley,et al.  Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy , 2012, Nature Medicine.

[13]  Hua Yu,et al.  A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.

[14]  Adriano D Andricopulo,et al.  Consensus hologram QSAR modeling for the prediction of human intestinal absorption. , 2012, Bioorganic & medicinal chemistry letters.

[15]  P. Cahill,et al.  Alcohol and Cardiovascular Disease—Modulation of Vascular Cell Function , 2012, Nutrients.

[16]  M. Cipolla,et al.  Inhibition of Protein Kinase C&bgr; Reverses Increased Blood–Brain Barrier Permeability During Hyperglycemic Stroke and Prevents Edema Formation In Vivo , 2011, Stroke.

[17]  Mark A Sussman,et al.  Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling. , 2011, Journal of molecular and cellular cardiology.

[18]  Bertram L Kasiske,et al.  Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). , 2011, Kidney international.

[19]  C. Ronco,et al.  The Cardiorenal Syndrome , 2011, International journal of nephrology.

[20]  C. Monaco,et al.  Toll‐like receptor signaling: Common pathways that drive cardiovascular disease and rheumatoid arthritis , 2011, Arthritis care & research.

[21]  L. Leng,et al.  Macrophage Migration Inhibitory Factor Promotes Cell Death and Aggravates Neurologic Deficits after Experimental Stroke , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[23]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[24]  J. Montaner,et al.  Osteopontin predicts long-term functional outcome among ischemic stroke patients , 2011, Journal of Neurology.

[25]  Yoshihiro Yamanishi,et al.  Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..

[26]  N. Campillo,et al.  Neural computational prediction of oral drug absorption based on CODES 2D descriptors. , 2010, European journal of medicinal chemistry.

[27]  R Scott Obach,et al.  Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. , 2010, Journal of medicinal chemistry.

[28]  Michael Böhm,et al.  Heart rate reduction in cardiovascular disease and therapy , 2010, Clinical Research in Cardiology.

[29]  Weidong Zhang,et al.  Analysis of the constituents in rat plasma after oral administration of Shexiang Baoxin pill by HPLC-ESI-MS/MS. , 2009, Biomedical chromatography : BMC.

[30]  Su-Jin Park,et al.  Rhodiosin, an Antioxidant Flavonol Glycoside from Rhodiola rosea , 2009 .

[31]  G. Firestone,et al.  Anticancer activities of artemisinin and its bioactive derivatives , 2009, Expert Reviews in Molecular Medicine.

[32]  S. Nef,et al.  Soy, phytoestrogens and metabolism: A review , 2009, Molecular and Cellular Endocrinology.

[33]  D. Sahota,et al.  Pharmacological investigation on the wound healing effects of Radix Rehmanniae in an animal model of diabetic foot ulcer. , 2009, Journal of ethnopharmacology.

[34]  J. Schrezenmeir,et al.  Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study , 2009, British Journal of Nutrition.

[35]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[36]  L. Hood,et al.  Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.

[37]  Anita M Saran,et al.  Cardiovascular disease in chronic kidney disease , 2008, Therapeutic advances in cardiovascular disease.

[38]  Hyunsu Bae,et al.  Evidence Based Complementary and Alternative Medicine , 2008, Evidence-based complementary and alternative medicine : eCAM.

[39]  Rinaldo Bellomo,et al.  Cardiorenal syndrome. , 2008, Journal of the American College of Cardiology.

[40]  J. Curb,et al.  Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. , 2008, The American journal of cardiology.

[41]  I. Mackraj,et al.  The Antihypertensive Effects of Quercetin in a Salt-sensitive Model of Hypertension , 2008, Journal of cardiovascular pharmacology.

[42]  C. Mineo,et al.  Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Russ B Altman,et al.  PharmGKB: a logical home for knowledge relating genotype to drug response phenotype , 2007, Nature Genetics.

[44]  D. Bers,et al.  Calmodulin and Ca2+/calmodulin kinases in the heart - physiology and pathophysiology. , 2007, Cardiovascular research.

[45]  Hyung Keun Kim,et al.  Down-regulation of iNOS and TNF-α expression by kaempferol via NF-κB inactivation in aged rat gingival tissues , 2007, Biogerontology.

[46]  D. Bers,et al.  Calmodulin and Ca 2+ /calmodulin kinases in the heart — Physiology and pathophysiology , 2007 .

[47]  Zhang Shu-wei.  Prediction of BBB permeation based on molecular indices , 2007 .

[48]  Xu Yan,et al.  Effects of Kanlijian on exercise tolerance, quality of life, and frequency of heart failure aggravation in patients with chronic heart failure , 2006 .

[49]  Foo-Tim Chau,et al.  Chemical information of Chinese medicines: A challenge to chemist , 2006 .

[50]  Yukiko Yamamoto,et al.  Antihypertensive Effect of Quercetin in Rats Fed with a High-Fat High-Sucrose Diet , 2006, Bioscience, biotechnology, and biochemistry.

[51]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[52]  Yan Xu,et al.  Effects of Kanlijian on exercise tolerance, quality of life, and frequency of heart failure aggravation in patients with chronic heart failure. , 2006, Chinese journal of integrative medicine.

[53]  B. Dijkmans,et al.  Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor β1 (TGFB1) gene polymorphisms , 2005, Annals of the rheumatic diseases.

[54]  P. Sidhu,et al.  Platelet degranulation and monocyte–platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack , 2004, British journal of haematology.

[55]  S. Gately,et al.  Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. , 2004, Seminars in oncology.

[56]  T. Hewett,et al.  PKC-α regulates cardiac contractility and propensity toward heart failure , 2004, Nature Medicine.

[57]  A. Rokach,et al.  Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease. , 2004, European heart journal.

[58]  S. Ventegodt,,et al.  Holistic Medicine: Scientific Challenges , 2003, TheScientificWorldJournal.

[59]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[60]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[61]  T. Murohara,et al.  Nitric oxide and angiogenesis in cardiovascular disease. , 2002, Antioxidants & redox signaling.

[62]  A. Reunanen,et al.  Flavonoid intake and risk of chronic diseases. , 2002, The American journal of clinical nutrition.

[63]  Susumu Minamisawa,et al.  ErbB2 is essential in the prevention of dilated cardiomyopathy , 2002, Nature Medicine.

[64]  X. Chen,et al.  TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..

[65]  N. Krinsky,et al.  Carotenoids as antioxidants. , 2001, Nutrition.

[66]  L. Liotta,et al.  Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  T. Lehtimäki,et al.  Association of polymorphism of human α oestrogen receptor gene with coronary artery disease in men: a necropsy study , 2000, BMJ : British Medical Journal.

[68]  J. Arnal,et al.  Endothelium-derived nitric oxide and vascular physiology and pathology , 1999, Cellular and Molecular Life Sciences CMLS.

[69]  D. Tribble.  Further evidence of the cardiovascular benefits of diets enriched in carotenoids. , 1998, The American journal of clinical nutrition.

[70]  F. Barone,et al.  Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. , 1994, Cerebrovascular and brain metabolism reviews.

[71]  W. Gesler.  Therapeutic landscapes: medical issues in light of the new cultural geography. , 1992, Social science & medicine.

[72]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .

[73]  F. Rosen,et al.  Congenital Cardiovascular Disease and Anomalies of the Third and Fourth Pharyngeal Pouch , 1972, Circulation.